The Use of Emetine for the Treatment of SARS-CoV-2 Infection

Description:
This technology includes the clinical use of the small compound emetine for the treatment of SARS-CoV-2. Previous work has shown that emetine has antiviral properties against some DNA and RNA viruses. It is thought that the mechanism may involve blocking protein synthesis. Work has shown that emetine has potential antiviral activity in multiple tissues that may make it suitable for the treatment of COVID-19.
Patent Information:
For Information, Contact:
Ami Gadhia
Technolgy and Patent Specialist
NIH Technology Transfer
301-827-7159
ami.gadhia@nih.gov
Inventors:
Mark Henderson
Juan Marugan
Andreas Dulcey Gracia
Xin Hu
Marc Ferrer-Alegre
Noel Southall
Keywords:
Emetine
Infection
SARS-CoV-2
treatment
VLXXXX
WIXXXX
WKXXXX
© 2024. All Rights Reserved. Powered by Inteum